Cargando…
Contrast Sensitivity Loss in Patients With Posttreatment Lyme Disease
PURPOSE: Posttreatment Lyme disease (PTLD) is marked by neurologic symptoms, cognitive impairment, and significant symptom burden, including fatigue and ocular complaints. The purpose of this study was to determine whether contrast sensitivity (CS) is altered in patients with PTLD compared with heal...
Autores principales: | Rebman, Alison W., Yang, Ting, Aucott, John N., Mihm, Erica A., West, Sheila K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995915/ https://www.ncbi.nlm.nih.gov/pubmed/34003960 http://dx.doi.org/10.1167/tvst.10.3.27 |
Ejemplares similares
-
The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome
por: Rebman, Alison W., et al.
Publicado: (2017) -
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients
por: Morrissette, Madeleine, et al.
Publicado: (2020) -
Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome
por: Novak, Cheryl, et al.
Publicado: (2017) -
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
por: Rebman, Alison W., et al.
Publicado: (2020) -
Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study
por: Rebman, Alison W, et al.
Publicado: (2021)